[1] |
Weerts, Z.Z.R.M.; Essers, B.A.B.; Jonkers, D.M.A.E.; Willems, J.I.A.; Janssen, D.J.P.A.; Witteman, B.J.M.; Clemens, C.H.M.; Westendorp, A.; Masclee, A.A.M.; Keszthelyi, D. A trial-based economic evaluation of peppermint oil for the treatment of irritable bowel syndrome. United Eur. Gastroenterol. J. 2021, 9, 997–1006.
|
[2] |
Zhao, J.; Chen, M.; Wang, X.; Ye, K.; Shi, S.; Li, H.; Wang, J.; Chen, X.; Ni, J.; Wei, Q.; Shi, Y.; Hu, Y.; Sun, J.; Li, D.; Liu, S.; Li, Z.; Zheng, H.; Yu, S.G. Efficacy of acupuncture in refractory irritable bowel syndrome: study protocol for a randomised controlled trial. BMJ Open. 2021, 11, e045655.
|
[3] |
Shah, A.; Gurusamy, S.R.; Hansen, T.; Callaghan, G.; Talley, N.J.; Koloski, N.; Walker, M.M.; Jones, M.P.; Morrison, M.; Holtmann, G.J. Concomitant irritable bowel syndrome does not influence the response to antimicrobial therapy in patients with functional dyspepsia. Dig. Dis. Sci. 2022, 67, 2299–2309.
|
[4] |
Bonetto, S.; Fagoonee, S.; Battaglia, E.; Grassini, M.; Saracco, G.; Pellicano, R. Recent advances in the treatment of irritable bowel syndrome. Polish Arch. Intern. Med. 2021, 131, 709–715.
|
[5] |
Fairbrass, K.M.; Selinger, C.P.; Gracie, D.J.; Ford, A.C. Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease. Neurogastroenterol. Motil. 2022, 34, e14256.
|
[6] |
Chen, G.R.; Xie, X.F.; Peng, C. Treatment of irritable bowel syndrome by Chinese medicine: a review. Chin. J. Integr. Med. 2021, 1–8.
|
[7] |
Zhang, F.; Xiang, W.; Li, C.Y.; Li, S.C. Economic burden of irritable bowel syndrome in China. World J. Gastroenterol. 2016, 22, 10450–10460.
|
[8] |
Shen, T.A.; Wu, X.H.; Feng, J.W.; Zhang, Z.N.; Wang, M.Y. Opposite sex contact and isolation to simultaneously prepare female and male depression/anxiety model rats. Acta Acad. Med. Wannan. 2019, 38, 9–11, 20.
|
[9] |
Zyoud, S.H.; Smale, S.; Waring, W.S.; Sweileh, W.; Al-Jabi, S.W. Global research trends in the microbiome related to irritable bowel syndrome: a bibliometric and visualized study. World J. Gastroenterol. 2021, 27, 1341–1353.
|
[10] |
Traini, C.; Idrizaj, E.; Garella, R.; Faussone-Pellegrini, M.S.; Baccari, M.C.; Vannucchi, M.G. Otilonium Bromide treatment prevents nitrergic functional and morphological changes caused by chronic stress in the distal colon of a rat IBS model. J. Cell Mol. Med. 2021, 25, 6988–7000.
|
[11] |
Bravo, J.A.; Dinan, T.G.; Cryan, J.F. Alterations in the central CRF system of two different rat models of comorbid depression and functional gastrointestinal disorders. Int. J. Neuropsychopharmacol. 2011, 14, 666–683.
|
[12] |
O’Malley D.; Dinan T.G.; Cryan J.F. Neonatal maternal separation in the rat impacts on the stress responsivity of central corticotropin-releasing factor receptors in adulthood. Psychopharmacology. 2011, 2141, 221–229.
|
[13] |
O’Mahony, S.M.; Marchesi, J.R.; Scully, P.; Codling, C.; Ceolho, A.M.; Quigley, E.M.; Cryan, J.F.; Dinan, T.G. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol. Psychiatry. 2009, 65, 263–267.
|
[14] |
Santos, T.; Baungratz, M.M.; Haskel, S.P.; de Lima, D.D.; da Cruz, J.N.; Magro, D.D.; da Cruz, J.G. Behavioral interactions of simvastatin and fluoxetine in tests of anxiety and depression. Neuropsychiatr. Dis. Treat. 2012, 8, 413–422.
|
[15] |
Klibaite, U.; Kislin, M.; Verpeut, J.L.; Bergeler, S.; Sun, X.; Shaevitz, J.W.; Wang, S.S. Deep phenotyping reveals movement phenotypes in mouse neurodevelopmental models. Mol. Autism. 2022, 13, 12.
|